Results 191 to 200 of about 1,050,694 (335)
Analysis and mining of Dupilumab adverse events based on FAERS database. [PDF]
Gao H, Cao L, Liu C.
europepmc +1 more source
As many patients with inflammatory arthritis (IA) have chronic pain, understanding how to best assess and manage pain in IA is a priority. Co‐morbid depression is prevalent in adults with IA, affecting 15 to 39% of people. Whilst pain and depression are thought to be associated in IA, this concept is largely based on cross‐sectional data.
Natasha Cox+3 more
wiley +1 more source
A programmatic assessment of dolutegravir adverse events and discontinuations in Uganda. [PDF]
Odongpiny EAL+12 more
europepmc +1 more source
Objective This study analyzed longitudinal trajectories of soluble fms‐like tyrosine kinase‐1 (sFlt‐1) and placental growth factor (PlGF) and sFlt‐1/PlGF ratio in a cohort of pregnant patients with systemic lupus erythematosus (SLE). Methods Blood samples were collected (14‐18, 24‐26, 30‐32, 34‐36 and 38‐40 weeks), stored at ‐80°C and evaluated for ...
Nilson R. de Jesús+7 more
wiley +1 more source
Real-World Pharmacovigilance Analysis of Adverse Events Associated with Liposomal Bupivacaine and Bupivacaine. [PDF]
Chen DX, Chen XM, Chen SM, Wang YD.
europepmc +1 more source
Development and validation of a Bayesian index for predicting major adverse cardiac events with percutaneous transluminal coronary angioplasty [PDF]
Adam J. de Belder
openalex +1 more source
Metabolic Consequences of Rheumatoid Arthritis
Patients with rheumatoid arthritis (RA) may have metabolic disruption, which can contribute to adverse long‐term outcomes, for multiple reasons. Patients with RA appear to have a higher risk of sarcopenia, type 1 and type 2 diabetes mellitus, metabolic syndrome, and hypertension. Systemic inflammation in RA can cause a “lipid paradox,” with reduced low‐
Stevie Barry+2 more
wiley +1 more source
Descriptive analysis of the national drug adverse events (AEs) database in Lebanon. [PDF]
Karam R+5 more
europepmc +1 more source